Todd E Schlesinger

Title
InstitutionMedical University of South Carolina
DepartmentFamily Medicine
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lampley N, Rigo R, Schlesinger T, Rossi AM. Field Therapy for Actinic Keratosis: A Structured Review of the Literature on Efficacy, Cost, and Adherence. Dermatol Surg. 2023 02 01; 49(2):124-129. PMID: 36728061.
      Citations:    Fields:    Translation:Humans
    2. Ross AS, Schlesinger T, Harmon CB, Moy RL, Rohrer TE, Mehregan DR, Nuccitelli R, Johnston LJ, Knape WA. Multicenter, prospective feasibility study of Nano-Pulse Stimulation? technology for the treatment of both nodular and superficial low-risk basal cell carcinoma. Front Oncol. 2022; 12:1044694. PMID: 36531070; PMCID: PMC9755735.
      Citations: 1     
    3. Schlesinger T, Stockfleth E, Grada A, Berman B. Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action. Clin Cosmet Investig Dermatol. 2022; 15:2495-2506. PMID: 36415541; PMCID: PMC9675993.
      Citations:    
    4. Schlesinger T. Commentary: Impact of Prior Treatment in the Efficacy and Tolerability of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies. J Clin Aesthet Dermatol. 2022 Oct; 15(10 Suppl 1):S11-S12. PMID: 36408373; PMCID: PMC9586523.
      Citations:    
    5. Del Rosso JQ, Johnson SM, Schlesinger T, Green L, Sanchez N, Lain E, Draelos Z, York JP, Chavda R. A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris. J Clin Aesthet Dermatol. 2022 Jul; 15(7):E53-E59. PMID: 35942016; PMCID: PMC9345187.
      Citations:    
    6. Brownstone N, Marson JW, Schlesinger T, Rigel D. Knowledge Gaps Among Dermatologists Regarding Immunotherapy for Non-melanoma Skin Cancer. J Clin Aesthet Dermatol. 2022 Jul; 15(7):24-25. PMID: 35942013; PMCID: PMC9345190.
      Citations:    
    7. Eisen DB, Schlesinger TE, Frazer-Green L, Eisen DB, Schlesinger TE, Frazer-Green L. Response to "Comment on 'Guidelines of care for the management of actinic keratosis'". J Am Acad Dermatol. 2023 02; 88(2):473. PMID: 35724891.
      Citations:    Fields:    Translation:Humans
    8. Eisen DB, Dellavalle RP, Frazer-Green L, Schlesinger TE, Shive M, Wu PA, Eisen DB, Dellavalle RP, Frazer-Green L, Schlesinger TE, Shive M, Wu PA. Focused update: Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2022 08; 87(2):373-374.e5. PMID: 35439607.
      Citations: 1     Fields:    Translation:Humans
    9. Zeitouni NC, Bhatia N, Ceilley RI, Cohen JL, Del Rosso JQ, Moore AY, Munavalli G, Pariser DM, Schlesinger T, Siegel DM, Willey A, Goldman MP, Zeitouni NC, Bhatia N, Ceilley RI, Cohen JL, Del Rosso JQ, Moore AY, Munavalli G, Pariser DM, Schlesinger T, Siegel DM, Willey A, Goldman MP. Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices. J Clin Aesthet Dermatol. 2021 Oct; 14(10):E53-E65. PMID: 34976292; PMCID: PMC8711613.
      Citations:    
    10. Rabinowits G, Migden MR, Schlesinger TE, Ferris RL, Freeman M, Guild V, Koyfman S, Pavlick AC, Swanson N, Wolf GT, Dinehart SM, Rabinowits G, Migden MR, Schlesinger TE, Ferris RL, Freeman M, Guild V, Koyfman S, Pavlick AC, Swanson N, Wolf GT, Dinehart SM. Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma. JID Innov. 2021 Dec; 1(4):100045. PMID: 34909742; PMCID: PMC8659794.
      Citations:    
    11. Eisen DB, Asgari MM, Bennett DD, Connolly SM, Dellavalle RP, Freeman EE, Goldenberg G, Leffell DJ, Peschin S, Sligh JE, Wu PA, Frazer-Green L, Malik S, Schlesinger TE, Eisen DB, Asgari MM, Bennett DD, Connolly SM, Dellavalle RP, Freeman EE, Goldenberg G, Leffell DJ, Peschin S, Sligh JE, Wu PA, Frazer-Green L, Malik S, Schlesinger TE. Guidelines of care for the management of actinic keratosis: Executive summary. J Am Acad Dermatol. 2021 10; 85(4):945-955. PMID: 34111497.
      Citations:    
    12. Eisen DB, Asgari MM, Bennett DD, Connolly SM, Dellavalle RP, Freeman EE, Goldenberg G, Leffell DJ, Peschin S, Sligh JE, Wu PA, Frazer-Green L, Malik S, Schlesinger TE, Eisen DB, Asgari MM, Bennett DD, Connolly SM, Dellavalle RP, Freeman EE, Goldenberg G, Leffell DJ, Peschin S, Sligh JE, Wu PA, Frazer-Green L, Malik S, Schlesinger TE. Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2021 10; 85(4):e209-e233. PMID: 33820677.
      Citations:    
    13. Schlesinger TE, Wilson AE, Trivedi L, Latham PJ, Ball R, Schlesinger TE, Wilson AE, Trivedi L, Latham PJ, Ball R. A Series of Tattoo-associated Mycobacterium Fortuitum Infections. J Clin Aesthet Dermatol. 2021 Apr; 14(4):38-40. PMID: 34055187; PMCID: PMC8142829.
      Citations:    
    14. Blauvelt A, Kempers S, Lain E, Schlesinger T, Tyring S, Forman S, Ablon G, Martin G, Wang H, Cutler DL, Fang J, Kwan MR, Blauvelt A, Kempers S, Lain E, Schlesinger T, Tyring S, Forman S, Ablon G, Martin G, Wang H, Cutler DL, Fang J, Kwan MR, Phase 3 Tirbanibulin for Actinic Keratosis Group. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis. N Engl J Med. 2021 02 11; 384(6):512-520. PMID: 33567191.
      Citations:    
    15. Kircik LH, Schlesinger TE, Tanghetti E, Kircik LH, Schlesinger TE, Tanghetti E. Efficacy and Safety of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam With Apremilast for Moderate Plaque Psoriasis. J Drugs Dermatol. 2020 Sep 01; 19(9):874-880. PMID: 33026749.
      Citations:    
    16. Lehman A, Pilcher B, Roberts WE, Schlesinger TE, Vachon G, Lehman A, Pilcher B, Roberts WE, Schlesinger TE, Vachon G. Postmarket Experience of Polymethylmethacrylate-Collagen Gel Dermal Filler. Dermatol Surg. 2020 08; 46(8):1086-1091. PMID: 31634252.
      Citations:    
    17. Biesman BS, Cohen JL, DiBernardo BE, Emer JJ, Geronemus RG, Gold MH, Lehman AS, Pilcher BK, Monheit GD, Schlesinger TE, Teller CF, Biesman BS, Cohen JL, DiBernardo BE, Emer JJ, Geronemus RG, Gold MH, Lehman AS, Pilcher BK, Monheit GD, Schlesinger TE, Teller CF. Treatment of Atrophic Facial Acne Scars With Microneedling Followed by Polymethylmethacrylate-Collagen Gel Dermal Filler. Dermatol Surg. 2019 12; 45(12):1570-1579. PMID: 30807389.
      Citations:    
    18. St Surin-Lord S, Schlesinger TE, Guenin E, St Surin-Lord S, Schlesinger TE, Guenin E. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-severe Acne Vulgaris in a Preadolescent and Adolescent Population. J Clin Aesthet Dermatol. 2019 Sep; 12(9):E57-E61. PMID: 31641421; PMCID: PMC6777705.
      Citations:    
    19. Schlesinger TE, Favre C, Schlesinger TE, Favre C. Enhancing Outcomes in Seborrheic Keratosis: Using a Novel Treatment Solution J Drugs Dermatol. 2019 Jul 01; 18(7):s178-182. PMID: 31336414.
      Citations:    
    20. Mills OH, Criscito MC, Schlesinger TE, Verdicchio R, Szoke E, Mills OH, Criscito MC, Schlesinger TE, Verdicchio R, Szoke E. Addressing Free Radical Oxidation in Acne Vulgaris. J Clin Aesthet Dermatol. 2016 Jan; 9(1):25-30. PMID: 26962389; PMCID: PMC4756869.
      Citations:    
    21. Schlesinger T, Rowland Powell C, Schlesinger T, Rowland Powell C. Efficacy and safety of a low molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis final report. J Clin Aesthet Dermatol. 2014 May; 7(5):15-8. PMID: 24847403; PMCID: PMC4025514.
      Citations:    
    22. Schlesinger TE, Cohen JL, Ellison S, Schlesinger TE, Cohen JL, Ellison S. Purpura and fillers: a review of pre-procedural, intra-procedural, and post-procedural considerations. J Drugs Dermatol. 2013 Oct; 12(10):1138-42. PMID: 24085049.
      Citations:    
    23. Schlesinger TE, Powell CR, Schlesinger TE, Powell CR. Efficacy and tolerability of low molecular weight hyaluronic acid sodium salt 0.2% cream in rosacea. J Drugs Dermatol. 2013 Jun 01; 12(6):664-7. PMID: 23839183.
      Citations:    
    24. Schlesinger T, Rowland Powell C, Schlesinger T, Rowland Powell C. Efficacy and safety of a low-molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis. J Clin Aesthet Dermatol. 2012 Oct; 5(10):20-3. PMID: 23125886; PMCID: PMC3486775.
      Citations:    
    25. Lyons JA, Schlesinger TE, Smith MD, Camisa C, Turner JM, Crowe J, Crownover RL, Lyons JA, Schlesinger TE, Smith MD, Camisa C, Turner JM, Crowe J, Crownover RL. Successful Breast Conservation in a Patient with Epidermolysis Bullosa Simplex. Breast J. 1999 Nov; 5(6):404-406. PMID: 11348322.
      Citations: 1     Fields:    
    Schlesinger's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (83)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _